comparemela.com
Home
Live Updates
Aurka Pathway - Breaking News
Pages:
Latest Breaking News On - Aurka pathway - Page 1 : comparemela.com
Alisertib Induces Early Signals of Efficacy in Endocrine-Resistant Breast Cancer
Alisertib as monotherapy and in combination with fulvestrant stands at the forefront of the clinical investigation of selective AURKA pathway inhibition in patients with endocrine-resistant advanced breast cancer, according to Tufia C. Haddad, MD.
United states
Tufiac haddad
Antonio dassoro
Practice innovation
Mayo clinic comprehensive cancer center
Antoniod assoro
Puma biotechnology
Aurka pathway
Endocrine resistant advanced breast cancer
A phase 2 trial nct02860000
Her2 negative metastatic breast cancer
vimarsana © 2020. All Rights Reserved.